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Background/Aims: The role of very early (≤12 hours) endoscopy in nonvariceal upper gastrointestinal bleeding is controversial. 
We aimed to compare results of very early and early (12–24 hours) endoscopy in patients with upper gastrointestinal bleeding 
demonstrating low-risk versus high-risk features and nonvariceal versus variceal bleeding.
Methods: This retrospective study included patients with nonvariceal and variceal upper gastrointestinal bleeding. The primary 
outcome was a composite of inpatient death, rebleeding, or need for surgery or intensive care unit admission. Endoscopy timing was 
defined as very early and early. We performed the analysis in two subgroups: (1) high-risk vs. low-risk patients and (2) variceal vs. 
nonvariceal bleeding.
Results: A total of 102 patients were included, of whom 59.8% underwent urgent endoscopy. Patients who underwent very early 
endoscopy received endoscopic therapy more frequently (p=0.001), but there was no improvement in other clinical outcomes. 
Furthermore, patients at low risk and with nonvariceal bleeding who underwent very early endoscopy had a higher risk of the 
composite outcome.
Conclusions: Very early endoscopy does not seem to be associated with improved clinical outcomes and may lead to poorer outcomes 
in specific populations with upper gastrointestinal bleeding. The actual benefit of very early endoscopy remains controversial and 
should be further clarified. Clin Endosc  2018 Oct 5. [Epub ahead of print]




Acute upper gastrointestinal bleeding (UGIB) is a frequent 
cause of hospital admission. The initial management is based 
on fluid resuscitation and blood transfusion whenever indi-
cated, followed by upper digestive endoscopy for both diag-
nostic and therapeutic purposes, with endoscopic hemostasis 
being the mainstay of treatment.1,2 
For nonvariceal UGIB, current guidelines recommend 
performing early endoscopy (within the first 24 hours of 
admission). Patients with high-risk features, including he-
modynamic instability refractory to volume resuscitation, 
bloody emesis/nasogastric aspirate during hospitalization, and 
contraindication to discontinuation of anticoagulants should 
be considered candidates for very early endoscopy (within 
the first 12 hours of admission).1 In cases of variceal bleeding, 
endoscopy should be performed within the first 12 hours.2,3
Nevertheless, the role of very early endoscopy (≤12 hours) 
in high-risk patients with nonvariceal bleeding is still con-
troversial and a matter of intense debate.4 Latest research re-
vealed that very early endoscopy leads to a higher probability 
of detecting high-risk lesions, warranting endoscopic inter-
vention without improved clinical results, including need for 
surgery or death.5-7 However, in those studies, patients were 
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not classified based on severity of bleeding, so it is unclear if 
the timing of endoscopy predicts clinical outcomes in high-
risk patients. On the other hand, Lim et al. concluded that the 
high-risk population, with a Glasgow Blatchford score (GBS) 
≥12, benefited from very early endoscopy and had a lower 
mortality rate.8 The results differ from those of Kumar et al., 
which showed that very early endoscopy was not associated 
with better clinical outcomes because it was a predictor of 
poorer outcomes in the low-risk population and had no effect 
on outcomes in high-risk patients.9 
Furthermore, most studies regarding the ideal timing of en-
doscopy in UGIB focused only on patients with nonvariceal 
bleeding and excluded those with variceal bleeding. However, 
when a patient presents with UGIB, the etiology of bleeding 
cannot be confirmed prior to endoscopy. Hence, in this study 
we included UGIB patients with variceal and nonvariceal 
bleeding. The importance of the timing of endoscopy in 
UGIB is further highlighted by the report of weekend effect, 
whereby the prognosis of patients presenting after hours may 
be worse.10,11
Our aim was to assess the relation between endoscopy tim-
ing and clinical outcomes in patients with UGIB admitted to 
a Portuguese emergency department and evaluate if patients 
with low versus high-risk features and variceal bleeding versus 
nonvariceal bleeding have different outcomes with very early 
versus early endoscopy.
MATERIAls And METhods
We conducted a retrospective cohort study, which included 
consecutive patients admitted with UGIB over a period of 10 
months, between January and October 2015. 
All patients underwent endoscopy in the first 24 hours since 
admission. Timing of endoscopy was defined as very early (≤12 
hours) and early (12–24 hours) from the time of admission, 
according to the current guidelines.1 Endoscopy timing was 
considered as the interval between arrival at hospital and the 
beginning of examination. Very early endoscopy was available 
on a 24/7 basis, according to the gastroenterologist’s decision. 
Hemostatic therapy was administered according to the most 
recent clinical evidence.
The primary composite outcome considered was death, 
bleeding recurrence, and need for surgery or intensive care 
unit (ICU) admission during hospital stay. Inpatient rebleed-
ing was defined as bleeding confirmed on repeat endoscopy. 
Secondary outcomes were also assessed, including need for 
endoscopic therapy, length of stay, and need for blood trans-
fusion. The medical files were periodically assessed to check 
for development of the above clinical outcomes. 
Demographic and medical history data were collected. Vi-
tal signs and blood test values were recorded to assess GBS, a 
widely studied score that can be assessed at the time of patient 
admission. GBS is the recommended score in the guidelines 
for nonvariceal bleeding,1 and it does not require results of 
endoscopy; hence, it was previously used in the literature for 
this purpose. We used it to classify patients as those at low-
risk (GBS <12) and high-risk (GBS ≥12).  
Patient data were presented using means and standard 
deviations or median and interquartile range for continuous 
variables and counts and percentages for categorical ones. 
Baseline features within subgroups were assessed with t-tests 
for the continuous variables and the Pearson chi-square test 
for the binary variables. Univariate relations between popu-
lation features and the composite outcomes were tested and 
presented with odds ratios (ORs) from logistic regression 
models. P-values <0.05 were considered significant. All anal-
yses were evaluated using SPSS (Statistical Package for Social 
Science) version 22. We also performed the statistical analysis 
in subgroups: (1) high versus low-risk patients, based on the 
GBS and (2) variceal versus nonvariceal bleeding.
REsUlTs
Patient characteristics
A total of 102 patients were included: 75.5% (n=77) were 
male and the mean age was 67 years (±14.17). Very early en-
doscopy was performed in 59.8% (n=61) and early endoscopy 
in 40.2% (n=41). The mean GBS was 10.1. None of the patients 
in the study had the need for interventional radiologic ther-
apy. The characteristics and clinical outcomes of the patients 
are available in Table 1. Tables 2 and 3 summarize the char-
acteristics and clinical outcomes of the very early vs. early 
endoscopy and nonvariceal vs. variceal bleeding subgroups, 
respectively.
Patient outcomes
At least one of the components of the primary composite 
outcomes was noted in 34 patients (33.3%): death in 6.9% 
(n=7), rebleeding in 14.7% (n=15), need for surgery in 5.9% 
(n=6), and ICU admission in 5.9% (n=6). All deaths occurred 
after the endoscopy. In terms of secondary outcomes, 50% 
(n=51) received endoscopic therapy, and 45.1% (n=46) re-
ceived one or more blood transfusions during admission. The 
mean number of erythrocyte concentrate units used for each 
patient was 2.7 (±3.1). The mean duration of hospital perma-
nence was 8.9 days (±5.2). 
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Predictors of composite outcome
Variceal bleeding (OR, 8.8; 95% confidence interval [CI], 
2.43–31.872; p<0.001) and time from admission to endoscopy 
(OR, 0.261; 95% CI, 0.113–0.602; p=0.001) were statistically 
significant predictors of the composite outcome, with a 73.9% 
lower risk of the composite outcome in cases of more time 
since admission to endoscopy. All other variables, including 
age, sex, GBS, and length of stay, were not significant predic-
tors (Table 4).
Very early versus early endoscopy
Those who underwent very early endoscopy were more 
likely to receive endoscopic therapy than those who under-
went early endoscopy (63.9% vs. 29.3%, p=0.001). We found 
no relation between timing of endoscopy and other clinical 
outcomes (Table 2).  
Effect of endoscopy timing according to patient’s 
risk
Seventy patients (68.6%) had low risk of bleeding. Of these, 
37 (52.9%) experienced one of the primary outcomes. Variceal 
bleeding (OR, 10.568; 95% CI, 2.191–50.967; p=0.001) and time 
to endoscopy (OR, 0.273; 95% CI, 0.100–0.743; p=0.01) were 
statistically significant factors with a decreased risk of 72.7% 
of reaching the composite outcome with early endoscopy, and 
32 (31.4%) patients had high-risk features. However, there 
were no predictors of the composite outcome, including en-
doscopy timing (p=0.130). As expected, deaths during hospi-
talization (p=0.004) and need for surgery (p=0.011) were more 
likely to occur in high-risk patients. The results are expressed 
in Tables 5 and 6.
Effect of the endoscopy timing according to bleed-
ing etiology
Seventy-seven patients (75.5%) were diagnosed with non-
variceal bleeding versus 25 (24.5%) with variceal bleeding. 
Variceal and nonvariceal bleeding were more frequent in 
males and females, respectively (p=0.027). Patients with vari-
ceal bleeding were more likely to receive endoscopic therapy 
(p<0.001) and reach the composite outcome (p<0.001). Pa-
tients with variceal bleeding had no different clinical out-
comes, whether they underwent very early or early endoscopy 
(p=0.231). However, patients with nonvariceal bleeding who 
underwent very early endoscopy were more likely to reach the 
composite endpoint (OR, 0.260; 95% CI, 0.098–0.687; p=0.006) 
and require surgical intervention (p=0.034). The results are 
summarized in Tables 7 and 8.
dIsCUssIon
In our study with 102 patients with UGIB, timing of en-
doscopy was revealed to be a predictor of clinical composite 
outcomes, including death, bleeding recurrence, and need for 
surgery or ICU admission. There was a 73.9% lower chance of 
experiencing the composite outcome with early rather than 
with very early endoscopy. When we analyzed the subgroups, 
very early endoscopy was a significant predictor of poorer re-
sults only in the low-risk group and patients with nonvariceal 
bleeding.
Some studies evaluated the role of timing of endoscopy on 
clinical results, mainly in patients with nonvariceal bleeding. 
However, they had different designs. Several previous studies 
revealed that in patients who undergo endoscopy earlier, the 
possibility of detecting high-risk bleeding lesions is greater, 
resulting in a higher rate of endoscopic intervention, than in 
patients who undergo endoscopy later. However, these studies 
did not show an improvement in the clinical results of pa-
tients, including death, bleeding recurrence, surgery, or hospi-
tal stay.5-7 Thus, previous research did not show a clear advan-
tage of very early endoscopy in UGIB. Two different studies 
Table 1. Characteristics and Clinical Outcomes of the Study Popula tion 
(n=102)
Age (yr) 67.18±14.17
Male sex 77 (75.5%)
Endoscopy timing
  Very early 61 (59.8%)
  Early 41 (40.2%)
Bleeding etiology
  Nonvariceal bleeding 77 (77.5%)
  Variceal Bleeding 25 (24.5%)
Patient risk
  Lower-risk 70 (68.6%)
  Higher-risk 32 (31.4%)
Glasgow-Blatchford score 10.1 (minimum: 0; 
maximum: 20)
Primary outcome
  Composite outcome 34 (33.3%)
Components of the primary outcome
  Inpatient death 7 (6.9%)
  Inpatient rebleeding 15 (14.7%)
  Surgical intervention 6 (5.9%)
  ICU admission 6 (5.9%)
Secondary outcomes
  Endoscopic intervention 51 (50.0%)
  Need for blood transfusion 46 (45.1%)
  Mean time of hospital stay (days) 8.9±5.2
Data are presented as mean±standard deviation or number (%).
ICU, intensive care unit.
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investigated if prognostic scores could help the decision of 
when to perform endoscopy.8,9 These studies stratified patients 
into low-risk (GBS <12) and high-risk (GBS ≥12) groups. Lim 
et al. concluded that in the high-risk group, endoscopy timing 
was the only significant predictor of death because 100% of 
the patients who underwent endoscopy in the first 13 hours 
survived, whereas there was a 44% mortality rate with later 
endoscopy.8
Our results are in accordance with previous data that did 
not reveal differences in mortality rates with very early vs. 
early endoscopy. Nevertheless, we saw an increased risk of a 
clinical composite outcome (death, rebleeding, or need for 
surgery or ICU admission) in patients who underwent very 
early endoscopy, especially those with low-risk features and 
nonvariceal bleeding. These results are in agreement with 
those of the study conducted by Kumar et al., which was the 
first to suggest a potential risk in performing early endoscopy.9 
The authors suggested that the low-risk population who had 
earlier access to endoscopy were not provided adequate fluid 
resuscitation because they may have seemed less unstable on 
presentation, and they pointed out that medical therapy and 
not the endoscopy timing was most crucial in preventing un-
favorable results in UGIB.9
Most studies in this field focus only on patients with non-
variceal bleeding, but prior to endoscopy, etiology of bleeding 
can only be speculated, so we included patients with variceal 
and nonvariceal bleeding in our study. To the best of our 
knowledge, we present the first research that stratified patients 
Table 2. Characteristics and Clinical Outcomes of Patients Receiving Very Early vs. Early Endoscopy (n=102)
Very early Early p-value
Number of patients 61 (59.8%) 41 (40.2%)
Age (yr) 67±14 73±13 0.503
Male sex 46 (75.4%) 31 (75.6%) 0.982
Bleeding etiology
   Nonvariceal bleeding 44 (72.1%) 33 (80.5%)
0.336
   Variceal Bleeding 17 (27.9%) 8 (19.5%)
Clinical and laboratory characteristics
   Any antiplatelet therapy 16 (26.2%) 13 (31.7%) 0.655
   Any anticoagulation 2 (3.3%) 7 (17.1%) 0.028
   Initial systolic blood pressure (mm Hg) 120 (37) 126 (22) 0.707
   Initial heart rate (bpm) 94 (33) 90 (26) 0.150
   Shock 29 (47.5%) 13 (31.7%) 0.151
   Altered mental status 10 (16.4%) 3 (7.3%) 0.233
   Hemoglobin (g/dL) 9.58±2.46 8.82±2.78 0.158
   Platelet count (x103/mL) 192 (124) 232 (209.5) 0.116
   INR 1.0 (0.3) 1.1 (0.4) 0.342
   Chronic liver disease 19 (31.3%) 9 (22.0%) 0.369
   Chronic kidney disease 2 (3.3%) 8 (19.5%) 0.013
Glasgow-Blatchford score 10.05±4.44 10.27±4.28 0.805
Primary outcome
   Composite outcome 42 (68.9%) 15 (36.6%) 0.001
Components of the primary outcome
   Inpatient death 4 (6.6%) 3 (7.3%) 1.0
   Inpatient rebleeding 10 (16.4%) 5 (12.2%) 0.557
   Surgical intervention 6 (9.8%) 0 (0.0%) 0.079
   ICU admission 6 (9.8%) 0 (0.0%) 0.079
Secondary outcomes
   Endoscopic intervention 39 (63.9%) 12 (29,3%) 0.001
   Need for blood transfusion 20 (32.8%) 26 (63.4%) 0.327
   Mean time of hospital stay (days) 7±4.8 8±5.4 0.629
Data are presented as mean±standard deviation or median (interquartile range) for continuous variables and as n (%) for categorical vari-
ables.
INR, international normalized ratio; ICU, intensive care unit.
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by bleeding severity and included both variceal and nonvari-
ceal bleeding patients. Our stratified analysis revealed that the 
timing of endoscopy was not an important predictor of the 
composite outcome in high-risk groups or patients with vari-
ceal bleeding.
Our study had limitations mainly because it was retrospec-
tive, and we relied on medical records to measure the data and 
Table 3. Characteristics and Clinical Outcomes of Patients with Nonvariceal vs. Variceal Bleeding (n=102)
nonvariceal bleeding Variceal bleeding p-value
Number of patients 77 (75.5%) 25 (24.5%)
Age (yr) 69.01±14.59 61.52±11.24 0.021
Male sex 54 (70.1%) 23 (92.0%) 0.027
Endoscopy timing
   Very early 44 (57.1%) 17 (68.0%)
0.336
   Early 33 (42.9%) 8 (32.0%)
Glasgow-Blatchford score 9.95±4.53 10.72±3.79 0.444
Primary outcome
   Composite outcome 35 (45.5%) 22 (88.0%) <0.001
Components of the primary outcome
   Inpatient death 5 (6.5%) 2 (8.0%) 1.0
   Inpatient rebleeding 9 (11.7%) 6 (24.0%) 0.19
   Surgical intervention 6 (7.8%) 0 (0.0%) 0.332
   ICU admission 3 (3.9%) 3 (12.0%) 0.156
Secondary outcomes
   Endoscopic intervention 30 (39.0%) 21 (84.0%) <0.001
   Blood transfusion 24 (31.2%) 22 (88.0%) 0.083
   Mean time of hospital stay (days) 7±3.9 9±5.4 0.047
Data are presented as mean±standard deviation or number (%).
ICU, intensive care unit.
Table 4. Analysis of Predictors of the Composite Outcome
odds ratio (95% CI) p-value
Age (yr) 0.518 (0.231–1.162) 0.109
Gender 0.656 (0.265–1.624) 0.361
Bleeding etiology 8.8 (2.43–31.872) <0.001
Glasgow-Blatchford score 1.486 (0.632–3.498) 0.363
Endoscopy timing 0.261 (0.113–0.602) 0.001
Length of stay 1.663 (0.754–3.669) 0.206
CI, confidence interval.
Table 6. Analysis of Predictors of the Composite Outcome in Higher Risk 
Patients
odds ratio (95% CI) p-value
Age (yr) 0.212 (0.022–2.032) 0.212
Gender 0.333 (0.073–1.521) 0.250
Bleeding etiology 5.923 (0.628–55.853) 0.204
Endoscopy timing 0.230 (0.052–1.100) 0.130
Length of stay 1.857 (0.432–7.978) 0.473
CI, confidence interval.
Table 5. Analysis of Predictors of the Composite Outcome in Lower Risk Pa-
tients
odds ratio (95% CI) p-value
Age (yr) 0.502 (0.194–1.302) 0.155
Gender 0.867 (0.268–2.798) 0.811
Bleeding etiology 10.568 (2.191–50.967) 0.001
Endoscopy timing 0.273 (0.100–0.743) 0.01
Length of stay 1.558 (0.604–4.017) 0.358
CI, confidence interval.
Table 7. Analysis of Predictors of the Composite Outcome in Nonvariceal 
Bleeding Patients
odds ratio (95% CI) p-value
Age (yr) 0.846 (0.331–2.164) 0.727
Gender 1.146 (0.431–3.048) 0.785
Endoscopy timing 0.260 (0.098–0.687) 0.006
Length of stay 1.467 (0.595–3.617) 0.405
CI, confidence interval.
Table 8. Analysis of Predictors of the Composite Outcome in Variceal Bleed-
ing Patients
odds ratio (95% CI) p-value
Age (yr) 0.233 (0.018–3.026) 0.530
Gender 0.095 (0.004–2.175) 0.230
Endoscopy timing 0.188 (0.014–2.468) 0.231
Length of stay 1.071 (0.083–13.896) 1.0
CI, confidence interval.
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outcomes of interest. Furthermore, the timing of endoscopy 
was left to the discretion of the treating physician. Therefore, 
it could be speculated that patients with severe bleeding (and 
therefore at higher risk of rebleeding and mortality), preferen-
tially underwent very early endoscopy, while those who were 
relatively hemodynamically stable preferentially underwent 
early endoscopy. Hence, it would be expected that the very 
early endoscopy group had worse outcomes. However, as 
shown in Table 2, clinical and laboratorial characteristics (such 
as GBS, hemoglobin, platelet count, International Normalized 
Ratio, blood pressure, heart rate, mental status, and comorbid-
ities) were not significantly different in the very early versus 
early group, which suggested a similar clinical severity be-
tween the two groups.
In conclusion, we found that timing of endoscopy was an 
important predictor of poorer outcomes in nonvariceal UGIB, 
with very early endoscopy (≤12 hours) associated with a high-
er chance of reaching a composite clinical outcome than early 
endoscopy (12–24 hours). Low-risk groups and patients with 
nonvariceal bleeding had poorer outcomes with very early en-
doscopy, whereas timing of endoscopy was not an important 
predictor in high-risk groups or patients with variceal bleed-
ing. As previously stated, we still believe that additional data 
and research are required to justify very early endoscopy in 
patients with bleeding of non-variceal etiologies, with tailored 
studies further defining subgroups that may benefit most 
from earlier intervention.4 This is still a matter of debate and a 
controversial topic. Previous studies have led to different con-
clusions, so further prospective research is required to clarify 
the importance of prognostic scores for acute UGIB and the 
ideal timing of endoscopy.
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